U.S. Asthma/COPD Market


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research service provides an in depth analysis of factors affecting the growth of the U.S. asthma/COPD market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts, and market share analysis. The market is segmented by mechanisms of action: anti-inflammatories, bronchodilators, and combination therapies. Major market challenges, drivers, and restraints and identified and discussed. Included are examinations of therapeutic candidates in the asthma/COPD pipeline for phase III.

Table of Contents

U.S. Asthma/COPD Market, Executive SummaryU.S. Asthma/COPD MarketIntroductionU.S. Asthma/COPD Market, Market IntroductionResearch Scope and MethodologyScope and SegmentationResearch MethodologyMarket OverviewAsthma Disease OverviewCOPD Disease OverviewMarket Engineering MeasurementsPatient Forecasts - AsthmaPatient Forecasts - COPDTotal Patient ForecastsIndustry ChallengesMarket DriversMarket RestraintsBronchodilators Product AnalysisShort-Acting Bronchodilators Product AnalysisLong-Acting Bronchodilators Product AnalysisAnticholinergics Product AnalysisCombination Bronchodilators Product AnalysisAnti-Inflammatories Product AnalysisInhaled Corticosteroids Product AnalysisAnti-Leukotriene Product AnalysisMonoclonal Antibodies Product AnalysisCombination Therapies Product AnalysisCombination Therapies Product AnalysisPipeline AnalysisPhase III Pipeline AnalysisU.S. Asthma/COPD Market, Competitive AnalysisTotal Market ForecastsRevenue Forecasts for Total Asthma/COPD MarketRevenue Forecasts for BronchodilatorsRevenue Forecasts for All BronchodilatorsRevenue Forecasts for Short-Acting BronchodilatorsRevenue Forecasts for Long-Acting BronchodilatorsRevenue Forecasts AnticholinergicsRevenue Forecasts for Combination BronchodilatorsRevenue Forecasts for Anti-InflammatoriesRevenue Forecasts for All Anti-InflammatoriesRevenue Forecasts for Inhaled Corticosteroids Revenue Forecasts for Anti-LeukotrienesRevenue Forecasts for Monoclonal AntibodiesRevenue Forecasts for Other Emerging Anti-InflammatoriesRevenue Forecasts for Combination TherapiesRevenue Forecasts for Combination TherapiesCompetitive AnalysisCompetitive StructureMarket Share AnalysisCompany Market ShareProduct Market ShareU.S. Asthma/COPD Market, AppendixDecision Support DatabasesMortality Due to Asthma-Bronchitis-and-EmphysemaPrevalence of AsthmaPrevalence of COPDMortality Due to Respiratory DiseaseTotal Population Over 65

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.